NCT01086423
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +23 more
- Locations
-
- GSK Investigational Site Wuzhou, Guangxi, China
- GSK Investigational Site Wuzhou, Guangxi, China
Clinical trial condition
Tetanus
Explore clinical trials studying Tetanus. Study availability and eligibility vary by location and protocol.
225 public trials
6 recruiting studies
Tetanus trial results
NCT00169442
- Conditions
- Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +21 more
- Locations
-
- GSK Investigational Site City of Muntinlupa, Philippines
- GSK Investigational Site Pasay, Philippines
- GSK Investigational Site Quezon City, Philippines
NCT00627458
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
- Locations
-
- GSK Investigational Site Jarvenpaa, Finland
- GSK Investigational Site Oulu, Finland
- GSK Investigational Site Pori, Finland
- GSK Investigational Site Tampere, Finland
NCT00412854
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
- Locations
-
- GSK Investigational Site Mengshan, China
- GSK Investigational Site Wuzhou, China
NCT00635128
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +24 more
- Locations
-
- GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany
- GSK Investigational Site Kehl, Baden-Wurttemberg, Germany
- GSK Investigational Site Oberkirch, Baden-Wurttemberg, Germany
- GSK Investigational Site Offenburg, Baden-Wurttemberg, Germany
NCT01449812
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +11 more
- Locations
-
- GSK Investigational Site Wuzhou, Guangxi, China
- GSK Investigational Site Wuzhou, Guangxi, China
Completed
Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults
NCT01323959
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
- Locations
-
- GSK Investigational Site Derval, France
- GSK Investigational Site La Chapelle-Basse-Mer, France
- GSK Investigational Site La Riche, France
- GSK Investigational Site Nantes, France
NCT00610168
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +12 more
- Locations
-
- GSK Investigational Site Turku, Finland
Completed
Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.
NCT00871000
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
- Locations
-
- GSK Investigational Site Genoa, Liguria, Italy
- GSK Investigational Site Milan, Lombardy, Italy
- GSK Investigational Site Novara, Piedmont, Italy
- GSK Investigational Site Cagliari, Sardinia, Italy
NCT00325143
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +23 more
- Locations
-
- GSK Investigational Site Singapore
- GSK Investigational Site Singapore
- GSK Investigational Site Singapore